These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6237633)

  • 1. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma.
    Wolf GT; Lovett EJ; Peterson KA; Beauchamp ML; Baker SR
    Arch Otolaryngol; 1984 Nov; 110(11):731-5. PubMed ID: 6237633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta endorphin enhances in vitro lymphokine production in patients with squamous carcinoma of the head and neck.
    Wolf GT; Peterson KA
    Otolaryngol Head Neck Surg; 1986 Feb; 94(2):224-9. PubMed ID: 2938055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
    Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocytes and impaired leukocyte migration inhibitory factor production in head and neck squamous carcinoma.
    Beauchamp ML; Wolf GT
    Head Neck Surg; 1988; 10(3):187-94. PubMed ID: 3069811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma.
    Wolf GT; Peterson KA; Lovett EJ
    Head Neck Surg; 1985; 7(5):350-6. PubMed ID: 3879957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis.
    Wolf GT; Schmaltz S; Hudson J; Robson H; Stackhouse T; Peterson KA; Poore JA; McClatchey KD
    Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1200-6. PubMed ID: 3499156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definite vs adjuvant radiotherapy. Comparative effects on lymphocyte subpopulations in patients with head and neck squamous carcinoma.
    Wolf GT; Amendola BE; Diaz R; Lovett EJ; Hammerschmidt RM; Peterson KA
    Arch Otolaryngol; 1985 Nov; 111(11):716-26. PubMed ID: 2932094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS; Johnson J; Claassen D
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte phenotypes at tumor margins in patients with head and neck cancer.
    Guo M; Rabin BS; Johnson JT; Paradis IL
    Head Neck Surg; 1987; 9(5):265-71. PubMed ID: 2957343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell subsets differ in their ability to migrate in vitro and to produce T cell migration inhibitory factor.
    Kowalczyk D; Pryjma J; Zembala M
    Immunol Lett; 1986 Aug; 13(1-2):33-8. PubMed ID: 2944820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell subpopulations in head and neck carcinoma.
    Johnson JT; Rabin BS; Hirsch B; Thearle PB
    Otolaryngol Head Neck Surg; 1984 Aug; 92(4):381-5. PubMed ID: 6237299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of lymphocyte subsets and natural killer cells in head and neck cancers. An immunohistological study using monoclonal antibodies.
    Harabuchi Y; Yamanaka N; Kataura A
    Arch Otorhinolaryngol; 1985; 242(1):89-97. PubMed ID: 3899069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of impaired leukocyte migration inhibition by thymosin in patients with head and neck squamous carcinoma.
    Wolf GT; Kerney SE; Chretien PB
    Am J Surg; 1980 Oct; 140(4):531-7. PubMed ID: 6999927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells.
    Berlinger NT; Hilal EY; Oettgen HF; Good RA
    Laryngoscope; 1978 Mar; 88(3):470-83. PubMed ID: 146766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of radiation therapy on T-lymphocyte subpopulations in patients with head and neck cancer.
    Gray WC; Chretien PB; Suter CM; Revie DR; Tomazic VT; Blanchard CL; Aygun C; Amornmarn R; Ordonez JV
    Otolaryngol Head Neck Surg; 1985 Oct; 93(5):650-60. PubMed ID: 2932670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific lymphokine responses in cervical nodes of patients with laryngeal cancer.
    Cortesina G; Beatrice F; Morra B; Barioglio MG; Poggio E; Bussi M; DiFortunato V; Sacchi M; Rendine S; Sartoris A
    Laryngoscope; 1987 Jul; 97(7 Pt 1):843-7. PubMed ID: 3298902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
    Acta Otolaryngol; 1998 Nov; 118(6):887-91. PubMed ID: 9870639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.